Pandion raises $58mm in Series A round
Pandion Therapeutics Inc. (bispecific antibodies for inflammatory and autoimmune diseases) raised $58mm through its Series A round. Seed investor Polaris Partners co-led the round, alongside Versant Ventures and Roche Venture Fund. BioInnovation Capital and SR One also took part.
- Large Molecule
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com